News & Events
Study Opens New Therapeutic Avenue For Mitochondria Malfunction
Jefferson scientists identify key interaction controlling calcium’s access to the cell’s powerhouse.
Pancreatic Cancer Genetic Marker May Predict Outcomes with Radiation Therapy
The discovery could influence oncologists’ treatment recommendations.
Shutting Down a Molecular Tunnel to Induce General Anesthesia
Jefferson study sheds new light on how the commonly used drug propofol blocks pain.
Lassa Fever Vaccine Shows Promise and Reveals New Test for Immunity
A new Lassa fever and rabies vaccine shows lasting immunity and suggests a new way to test for protection.
Seizures Begin with a Muffle
Contrary to long-held assumptions, researchers find that some seizures start after a burst from neurons that inhibit brain activity.
Jefferson Partners on Small Business Innovation Grant for New Drug to Treat Lung Fibrosis
Jefferson and Fox Chase Chemical Diversity Center, Inc. awarded Innovative grant for the co-development of a novel, first-in-class treatment for idiopathic pulmonary fibrosis.
Combination Therapy of Prostatectomy Plus Radiotherapy May Improve Survival in Patients with Locally Advanced Prostate Cancer
A comparison of two of the most common combination therapies for locally advanced prostate cancer show the more aggressive option is linked with a higher rate of survival.
Distance Helps Re-fuel the Heart
Separated entry and exit doors for calcium keep energy production smooth in the powerhouses of heart cells.
New Study Reveals A Method That Slows Cognitive Decline in Older Blacks with Memory Loss
A behavioral treatment that helps adults set goals toward a more active social, cognitive, and physical lifestyle can reduce memory decline, in a randomized controlled trial.
Total Ankle Arthroplasty Offers Patients Greater Range of Motion, Less Pain and Better Function
New research reveals patients with end-stage ankle arthritis can expect enhanced quality of life within six months of surgical reconstruction.